tm logo
SILANES
Live/Registered
REGISTERED AND RENEWED

on 21 May 2019

Last Applicant/ Owned by

Avenida Paseo de las Palmas No. 340

Ciudad de MĂ©xico

MX

11000

Serial Number

75176361 filed on 03rd Oct 1996

Registration Number

2241440 registered on 27th Apr 1999

in the Principal Register

Correspondent Address

Jason L DeFrancesco

Jason L DeFrancesco

21 Roszel Rd.

Princeton NJ 08540

Filing Basis

1. intent to use

Disclaimer

NO DATA

SILANES

pharmaceuticals, namely, injectable solutions, tablets, pills and capsules for adults and children, oral suspension, medicated syrup and ointment, all for treatment as a cough suppressant, and expectorant, [ activity against anaerobic bacteria, Trichomona vaginalis, Entamoeba histolytica, and giardia lamblia, ] as an antifungal agent for treatment of Oropharyngeal and esophageal candidiasis, [ can Read More

Classification Information


Class [005]
Pharmaceutical Products


pharmaceuticals, namely, injectable solutions, tablets, pills and capsules for adults and children, oral suspension, medicated syrup and ointment, all for treatment as a cough suppressant, and expectorant, [ activity against anaerobic bacteria, Trichomona vaginalis, Entamoeba histolytica, and giardia lamblia, ] as an antifungal agent for treatment of Oropharyngeal and esophageal candidiasis, [ candidial urinary tract infections, peritonitis and systemic candidal infections, candidemia, disseminated candidiasis and pneumonia, cryptococcal meningitis, candidal genital tract infections, ] as an analgesis anti-inflamatory non steroidal inhibitor of prostaglandin synthetase, [ analgesic and minor tranquilizer, active immunization against tetanus, peripheral neuritis, neuralgias, peripheral neuritis, neuralgias and haematopoietic, antifungal agent for treatment of systemic blastomycosis, histoplasmosis paracoccidloidomycosis, fungal infection of the gastrointestinal tract and tinea infections of the skin, and nails, sulphonylurea and biguanide, hipoglycaemic agent, activity against trichomonas vaginalis, entamoeba histolytica and Giardia lamblia, anaerobic bacteria, ] histamine H1-receptor antagonist and prophylactic treatment of asthma, and treatment of allergic conditions such as rhinitis and conjuntivitis,[ analgesic, ] anti-inflamatory non steroidal, for inhibiting prostaglanding synthetase, [ analgesic, anti-inflammatory non steroidal, inhibitor of prostaglandin synthetase ] and muscle relaxant, analgesic, antipyretic, [ sulphonylurea hipoglycaemic agent, for inhibiting as an angiotensin-converting enzyme, treatment of congestive heart failure and asymptomatic left ventricular dysfunction, diuretic treatment of congestive heart failure, hypertension, cardiac, renal hepatogenic oedema, peripheral neuritis, neuralgias and analgesic, ] a broad spectrum antibiotic, effective against a wide range of Gram positive and Gram negative aerobic and anaerobic bacterias, [ histamin H2-receptor antagonist in the treatment of gastric an duodenal ulcer, Zollinger-Ellison syndrome, iron deficiency and anemia for children or adults, ] anixolytic, anticonvulsant, sedative, muscle relaxant, [ histamine H2-receptor antagonist in the treatment of gastric and duodenal ulcer Zollinger-Ellison syndrome, ] multivitamin treatment and prevention of vitamin B1-B6-B12 deficiency, [ tricyclic antidepressant, treatment of nocturnal enuresis in children, inhibits angiotensin-converting enzyme, ] treatment of hypertension and congestive heart failure, treatment and prevention of vitamic C deficiency, treatment and prevention of seborrhoea and dandruff, analgesic no narcotic

Mark Details


Serial Number

No 75176361

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
16th Jan 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16th Jan 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21st May 2019REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
21st May 2019REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
21st May 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
20th May 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
16th Apr 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
16th Apr 2019TEAS SECTION 8 & 9 RECEIVED
27th Apr 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
26th Feb 2009REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED